Starting April 21, you’ll be asked to log in or sign up for a free account after viewing 10 content pages each month.
Don’t worry—creating an account is quick and easy, and it comes with added benefits! Once logged in, you’ll not only continue accessing the content you already enjoy, but you’ll also unlock exclusive features like interactive donut plots for variant protein effects and variant impacts across the gene.
Stay tuned for these updates, and thank you for being part of our community!
Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | SD-101 |
Trade Name | |
Synonyms | SD101|SD 101 |
Drug Descriptions |
SD-101 is an oligonucleotide which interacts with Toll-Like Receptor 9 (TLR9) and activates memory T helper cells 1 (Th1) (PMID: 30154193, PMID: 31921384). |
DrugClasses | TLR9 Agonist 9 |
CAS Registry Number | NA |
NCIT ID | C74084 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
BMS-986178 + SD-101 | BMS-986178 SD-101 | 0 | 2 |
Epacadostat + SD-101 | Epacadostat SD-101 | 0 | 1 |
Ibrutinib + Radiotherapy + SD-101 | Ibrutinib Radiotherapy SD-101 | 0 | 1 |
Ipilimumab + Nivolumab + SD-101 | Ipilimumab Nivolumab SD-101 | 0 | 2 |
Ipilimumab + SD-101 | Ipilimumab SD-101 | 0 | 1 |
MK-1966 + SD-101 | MK-1966 SD-101 | 0 | 1 |
Nivolumab + SD-101 | Nivolumab SD-101 | 0 | 1 |
Pembrolizumab + SD-101 | Pembrolizumab SD-101 | 0 | 3 |
SD-101 | SD-101 | 0 | 4 |